The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Ruthenium complexes can target determinants of tumour malignancy
Abstract
Metastases are more decisive for tumour prognosis than primary lesions, because of their multiple locations, low accessibility to surgery and/or radiotherapy, and generally poor responsiveness to chemotherapy. The metastasis should therefore be the primary target for drug therapy. Among ruthenium complexes, NAMI-A is a leading compound that shows selective effects for solid tumour metastases related to a mechanism of action involving the inhibition of the processes of tumour invasiveness. NAMI-A opens an avenue to new perspectives in cancer chemotherapy. This includes novel compounds directed at targets selectively expressed by tumour metastases, thus reducing the typical side effects of the current metal-based drugs that are active via their unselective DNA interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Glutathione and its role in cellular functions
Sies, H. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00177-x · Cited by 1,735
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
New metal complexes as potential therapeutics
Zhang, C. X., & Lippard, S. J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00081-4 · Cited by 946
The role of glutathione in cancer
Balendiran, G. K., Dabur, R., & Fraser, D. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 927
Branford, S., Rudzki, Z., Walsh, S., Parkinson, I., Grigg, A., Szer, J., Taylor, K., Herrmann, R., Seymour, J. F., Arthur, C., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2896 · Cited by 765
Toxicity of platinum compounds
Hartmann, J. T., & Lipp, H.-P. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.6.889 · Cited by 604
Pharmacological inhibitors of glycogen synthase kinase 3
MEIJER, L., FLAJOLET, M., & GREENGARD, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.006 · Cited by 584
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Wang, W., Goswami, S., Lapidus, K., Wells, A. L., Wyckoff, J. B., Sahai, E., Singer, R. H., Segall, J. E., & Condeelis, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1136 · Cited by 455
THE GREAT ESCAPE: When Cancer Cells Hijack the Genes for Chemotaxis and Motility
Condeelis, J., Singer, R. H., & Segall, J. E. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120306 · Cited by 391
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
Brabec, V., & Nováková, O. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.002 · Cited by 384
Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
ReviewRegulation of protein function by glutathionylation
Ghezzi, P. (2005) · Free Radical Research · doi:10.1080/10715760500072172 · Cited by 270
Schnelldorfer, T., Gansauge, S., Gansauge, F., Schlosser, S., Beger, H. G., & Nussler, A. K. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1440::aid-cncr5>3.0.co;2-0 · Cited by 246
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex
Sava, G., Capozzi, I., Clerici, K., Gagliardi, G., Alessio, E., & Mestroni, G. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006521715400 · Cited by 183
Self-citationAnticancer metal compounds in NCI's tumor-screening database: putative mode of action
Huang, R., Wallqvist, A., & Covell, D. G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.001 · Cited by 169
Bergamo, A., Gagliardi, R., Scarcia, V., Furlani, A., Alessio, E., Mestroni, G., & Sava, G. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38169-8 · Cited by 160
Self-citationCisplatin and Related Anticancer Drugs: Recent Advances and Insights
Barnes, K. R., & Lippard, S. J. (2004) · CRC Press eBooks · doi:10.1201/b12414-5 · Cited by 147
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
Vacca, A., Bruno, M., Boccarelli, A., Coluccia, M., Ribatti, D., Bergamo, A., Garbisa, S., Sartor, L., & Sava, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600176 · Cited by 140
Self-citationToxicities of the platinum antineoplastic agents
Markman, M. M. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.6.597 · Cited by 137
Nováková, O., Kašpárková, J., Bursová, V., Hofr, C., Vojtíšková, M., Chen, H., Sadler, P. J., & Brabec, V. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.008 · Cited by 136
Targeting Gsk-3: A Promising Approach For Cancer Therapy?
Ougolkov, A. V., & Billadeau, D. D. (2006) · Future Oncology · doi:10.2217/14796694.2.1.91 · Cited by 130
An Organometallic Inhibitor for Glycogen Synthase Kinase 3
Bregman, H. S., Williams, D. S., Atilla, G. E., Carroll, P. J., & Meggers, E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja046049c · Cited by 127
Carretero, J., Obrador, E., Anasagasti, M. J., Martin, J. J., Vidal‐Vanaclocha, F., & Estrela, J. M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006725226078 · Cited by 125
Zorzet, S., Bergamo, A., Cocchietto, M., Sorc, A., Gava, B., Alessio, E., Iengo, E., & Sava, G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38990-6 · Cited by 120
Self-citationAtilla‐Gokcumen, G. E., Williams, D. S., Bregman, H. S., Pagano, N., & Meggers, E. (2006) · ChemBioChem · doi:10.1002/cbic.200600117 · Cited by 118
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
Macaluso, M., Paggi, M. G., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206955 · Cited by 112
Gava, B., Zorzet, S., Spessotto, P., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095141 · Cited by 94
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
Morbidelli, L., Donnini, S., Filippi, S., Luigi Messori, A., Piccioli, F., Orioli, P., Sava, G., & Ziche, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600906 · Cited by 92
Self-citationThe Evolving Portrait of Cancer MetastasisPreprint
Gupta, P. B., Mani, S. A., YANG, J., Hartwell, K. A., & Weinberg, R. A. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.033 · Cited by 92
Sava, G., Frausin, F., Cocchietto, M., Vita, F., Podda, E., Spessotto, P., Furlani, A., Scarcia, V., & Zabucchi, G. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.034 · Cited by 91
Self-citationSatraplatin: an orally available platinum analog for the treatment of cancer
Choy, H. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.7.973 · Cited by 88
Timerbaev, A. R., Rudnev, A. V., Semenova, O. P., Hartinger, C. G., & Keppler, B. K. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.020 · Cited by 84
S-glutathionylation in human platelets by a thiol–disulfide exchange-independent mechanism
Dalle‐Donne, I., Giustarini, D., Colombo, R., Milzani, A., & Rossi, R. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.019 · Cited by 78
O’Brian, C. A., & Chu, F. (2005) · Free Radical Research · doi:10.1080/10715760500073931 · Cited by 73
Pintus, G., Tadolini, B., Posadino, A. M., Sanna, B., Debidda, M., Bennardini, F., Sava, G., & Ventura, C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03307.x · Cited by 71
Self-citationMolecular mechanisms of metastasis
Hoon, D. S. �., Kitago, M., Kim, J., Mori, T., Piris, A., Masterpol, K. S., Mihm, M. C., Nathanson, S. D., Padera, T. P., Chambers, A. F., et al. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-8500-x · Cited by 69
Gene Expression Profiling of Human Cancers
Bucca, G., Carruba, G., Saetta, A., Muti, P., CASTAGNETTA, L. A. M., & Smith, C. P. S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.003 · Cited by 67
Sanna, B., Debidda, M., Pintus, G., Tadolini, B., Posadino, A. M., Bennardini, F., Sava, G., & Ventura, C. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00218-7 · Cited by 60
Self-citationAdvances in the Treatment of Testicular Cancer
Kopp, H., Kuczyk, M. A., Claßen, J., et al. (2006) · Drugs · doi:10.2165/00003495-200666050-00005 · Cited by 60
GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells
Honda, T., Coppola, S., Ghibelli, L., Cho, S. H., Kagawa, S., Spurgers, K. B., Brisbay, S. M., Roth, J. A., Meyn, R. E., Fang, B., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700684 · Cited by 56
Genomics and the second golden era of cancer drug development
Workman, P. (2005) · Molecular BioSystems · doi:10.1039/b501751n · Cited by 49
Antitumor Active Trans-Platinum Compounds
Natile, G., & Coluccia, M. (2004) · CRC Press eBooks · doi:10.1201/b12414-7 · Cited by 46
Cited by
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Zhao, X., Liu, J., Fan, J., Chao, H., & Peng, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00173b · Cited by 1,270
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
Metadata
- Authors
- Bergamo, A., & Sava, G.
- Venue
- Dalton Transactions
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2007
- Issue
- 13
- Pages
- 1267
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2083088228
- Cited by
- 291
- References
- 51
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.